131 related articles for article (PubMed ID: 24504620)
1. Monomethylfumarate reduces in vitro migration of mononuclear cells.
Dehmel T; Döbert M; Pankratz S; Leussink VI; Hartung HP; Wiendl H; Kieseier BC
Neurol Sci; 2014 Jul; 35(7):1121-5. PubMed ID: 24504620
[TBL] [Abstract][Full Text] [Related]
2. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
3. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
4. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies.
Gopal S; Mikulskis A; Gold R; Fox RJ; Dawson KT; Amaravadi L
Mult Scler; 2017 Dec; 23(14):1875-1883. PubMed ID: 28156185
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Lim JL; van der Pol SM; Di Dio F; van Het Hof B; Kooij G; de Vries HE; van Horssen J
Microvasc Res; 2016 May; 105():61-9. PubMed ID: 26679389
[TBL] [Abstract][Full Text] [Related]
6. Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Kopadze T; Döbert M; Leussink VI; Dehmel T; Kieseier BC
Eur J Neurol; 2009 Mar; 16(3):409-12. PubMed ID: 19175384
[TBL] [Abstract][Full Text] [Related]
7. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions.
Wallbrecht K; Drick N; Hund AC; Schön MP
Exp Dermatol; 2011 Dec; 20(12):980-5. PubMed ID: 21995308
[TBL] [Abstract][Full Text] [Related]
9. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
10. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses.
Litjens NH; Rademaker M; Ravensbergen B; Rea D; van der Plas MJ; Thio B; Walding A; van Dissel JT; Nibbering PH
Eur J Immunol; 2004 Feb; 34(2):565-75. PubMed ID: 14768062
[TBL] [Abstract][Full Text] [Related]
11. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M
Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203
[TBL] [Abstract][Full Text] [Related]
12. Influence of monomethylfumarate on monocytic cytokine formation--explanation for adverse and therapeutic effects in psoriasis?
Asadullah K; Schmid H; Friedrich M; Randow F; Volk HD; Sterry W; Döcke WD
Arch Dermatol Res; 1997 Oct; 289(11):623-30. PubMed ID: 9444385
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.
Kopadze T; Dehmel T; Hartung HP; Stüve O; Kieseier BC
Arch Neurol; 2006 Nov; 63(11):1572-8. PubMed ID: 17101825
[TBL] [Abstract][Full Text] [Related]
14. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
[TBL] [Abstract][Full Text] [Related]
15. Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression.
Helwa I; Choudhary V; Chen X; Kaddour-Djebbar I; Bollag WB
J Pharmacol Exp Ther; 2017 Aug; 362(2):243-253. PubMed ID: 28515158
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proton-coupled folate transporter in retinal Müller cells by the antipsoriatic drug monomethylfumarate.
Bozard BR; Chothe PP; Tawfik A; Williams C; Fulzele S; Prasad PD; Martin PM; Ganapathy V; Smith SB
Glia; 2012 Mar; 60(3):333-42. PubMed ID: 22072423
[TBL] [Abstract][Full Text] [Related]
17. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
[TBL] [Abstract][Full Text] [Related]
18. Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia.
Kronenberg J; Pars K; Brieskorn M; Prajeeth CK; Heckers S; Schwenkenbecher P; Skripuletz T; Pul R; Pavlou A; Stangel M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30650518
[TBL] [Abstract][Full Text] [Related]
19. Induction of the cystine/glutamate exchanger SLC7A11 in retinal pigment epithelial cells by the antipsoriatic drug monomethylfumarate.
Ananth S; Babu E; Veeranan-Karmegam R; Bozard Baldowski BR; Boettger T; Martin PM
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1592-602. PubMed ID: 23404113
[TBL] [Abstract][Full Text] [Related]
20. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
